Coronavirus vaccine trials: Bharat Biotech said that it is steadily moving towards its goal of 26,000 volunteers. Phase 3 of human clinical trials for Covaxin began in mid-November
A sample number of beneficiaries will undergo a mock immunisation process. Staff of vaccination centres, a select group of healthcare workers will participate in the mock immunisation drive
Coronavirus vaccine trials: Earlier officials had said that people are unwilling to participate in the exercise thinking why take part in the trials when the vaccine would soon be available for everybody